Ropes & Gray Represents Sanofi in Investment in AgomAb Therapeutics

In The News
October 28, 2024

Ropes & Gray represented Sanofi as it participated in AgomAb Therapeutics’ $89 million Series D financing round.  AgomAb is an Antwerp, Belgium-based biopharma company focused on achieving disease modification by modulating fibrosis and regeneration in chronic indications such as fibrostenosing Crohn’s disease and idiopathic pulmonary fibrosis. The transaction was announced on October 25.

The Ropes & Gray team included strategic transactions associate Courtney Sy and venture capital and emerging companies partner Rajarshi Banerjee.